Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
Clinical trial NCT01526837 · TERMINATED
Trial details
- NCT number
- NCT01526837
- Sponsor
- Brain & Spine Surgeons of New York
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-01-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.